Addex Therapeutics Stock Z Score

ADXN Stock  USD 7.95  0.06  0.76%   
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Addex Therapeutics Piotroski F Score and Addex Therapeutics Valuation analysis.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.
  
At this time, Addex Therapeutics' Capital Lease Obligations is very stable compared to the past year. As of the 12th of December 2024, Change In Working Capital is likely to grow to about 224.4 K, while Capital Surpluse is likely to drop about 297.8 M. At this time, Addex Therapeutics' Total Revenue is very stable compared to the past year. As of the 12th of December 2024, Other Operating Expenses is likely to grow to about 16.8 M, while Depreciation And Amortization is likely to drop about 290.7 K.

Addex Therapeutics Company Z Score Analysis

Addex Therapeutics' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

 = 

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

 = 

1.2 * (

Working Capital

/

Total Assets )

Second Factor

 = 

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

 = 

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

 = 

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

 = 

0.99 * (

Revenue

/

Total Assets )

Addex Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Addex Therapeutics is extremely important. It helps to project a fair market value of Addex Stock properly, considering its historical fundamentals such as Z Score. Since Addex Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Addex Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Addex Therapeutics' interrelated accounts and indicators.
0.990.08-0.990.570.580.661.00.06-0.190.310.450.46-0.110.010.520.520.37
0.990.05-0.990.610.560.560.990.01-0.20.30.430.47-0.13-0.050.540.540.37
0.080.05-0.14-0.280.50.260.140.660.650.45-0.510.470.360.650.440.450.06
-0.99-0.99-0.14-0.53-0.6-0.61-1.0-0.090.11-0.36-0.36-0.550.06-0.04-0.6-0.6-0.37
0.570.61-0.28-0.530.140.070.53-0.41-0.66-0.170.59-0.25-0.63-0.51-0.15-0.150.39
0.580.560.5-0.60.140.470.610.690.310.460.030.520.330.590.520.520.16
0.660.560.26-0.610.070.470.630.36-0.030.270.370.20.110.410.210.220.17
1.00.990.14-1.00.530.610.630.1-0.110.360.370.54-0.060.050.590.590.37
0.060.010.66-0.09-0.410.690.360.10.580.37-0.360.370.690.960.290.3-0.18
-0.19-0.20.650.11-0.660.31-0.03-0.110.580.32-0.590.510.720.590.410.41-0.29
0.310.30.45-0.36-0.170.460.270.360.370.32-0.380.70.090.490.730.740.74
0.450.43-0.51-0.360.590.030.370.37-0.36-0.59-0.38-0.39-0.44-0.41-0.32-0.330.02
0.460.470.47-0.55-0.250.520.20.540.370.510.7-0.390.410.390.990.990.23
-0.11-0.130.360.06-0.630.330.11-0.060.690.720.09-0.440.410.690.270.27-0.53
0.01-0.050.65-0.04-0.510.590.410.050.960.590.49-0.410.390.690.320.33-0.07
0.520.540.44-0.6-0.150.520.210.590.290.410.73-0.320.990.270.321.00.34
0.520.540.45-0.6-0.150.520.220.590.30.410.74-0.330.990.270.331.00.35
0.370.370.06-0.370.390.160.170.37-0.18-0.290.740.020.23-0.53-0.070.340.35
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Competition

In accordance with the company's disclosures, Addex Therapeutics has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

Addex Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Addex Therapeutics' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Addex Therapeutics could also be used in its relative valuation, which is a method of valuing Addex Therapeutics by comparing valuation metrics of similar companies.
Addex Therapeutics is currently under evaluation in z score category among its peers.

Addex Therapeutics Current Valuation Drivers

We derive many important indicators used in calculating different scores of Addex Therapeutics from analyzing Addex Therapeutics' financial statements. These drivers represent accounts that assess Addex Therapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Addex Therapeutics' important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap43.3M53.1M35.5M4.5M3.4M3.2M
Enterprise Value12.3M35.0M15.5M(2.0M)(103.0K)(97.8K)

Addex Therapeutics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Addex Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Addex Therapeutics' managers, analysts, and investors.
Environmental
Governance
Social

Addex Therapeutics Institutional Holders

Institutional Holdings refers to the ownership stake in Addex Therapeutics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Addex Therapeutics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Addex Therapeutics' value.
Shares
Adar1 Capital Management Llc2024-09-30
1000
Morgan Stanley - Brokerage Accounts2024-09-30
353
Rhumbline Advisers2024-09-30
35.0

Addex Fundamentals

About Addex Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Addex Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Addex Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Addex Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Addex Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Addex Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Addex Stock

  0.77VALN Valneva SE ADRPairCorr
  0.68ERNA Eterna TherapeuticsPairCorr

Moving against Addex Stock

  0.7DYAI Dyadic InternationalPairCorr
  0.65BMY Bristol Myers SquibbPairCorr
  0.62ESPR Esperion TherapeuticsPairCorr
  0.37GILD Gilead SciencesPairCorr
The ability to find closely correlated positions to Addex Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Addex Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Addex Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Addex Therapeutics to buy it.
The correlation of Addex Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Addex Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Addex Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Addex Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Addex Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Addex Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Addex Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Addex Therapeutics Stock:
Check out Addex Therapeutics Piotroski F Score and Addex Therapeutics Valuation analysis.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(21.75)
Revenue Per Share
1.2
Quarterly Revenue Growth
(0.82)
Return On Assets
(0.62)
Return On Equity
(1.26)
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.